Rare Disease and Orphan Drugs Journal, is a peer-reviewed, open-access, quarterly published online journal launched by OAE Publishing Inc. in April, 2021.
The journal aims to provide a forum for scientific studies and discussion covering the important regulatory, socio-economic and human science issues related to rare diseases and orphan drugs. Prof. Daniel Scherman from Paris University, Fondation Maladies Rares, France, is the Editor-in-Chief.
Push the boundaries of Human Data Science
As a result of the merger of IMS Health, a world leader in data analysis & technology solutions exclusively in the field of Health, and Quintiles, one of the world’s leading companies in Clinical Studies, IQVIA, based in the USA, has a presence in 100+ countries with 75K employees.
In Greece, we have been active since 1968, counting now more than 200 employees and collaborating with all Healthcare professionals as well as Hospitals. In numerical terms, IQVIA Hellas has a network of 3.5K doctors and 3K pharmacies for data collection & primary research studies, while conducting at least 120 clinical studies at over 100 sites. We also work closely with all partners in Healthcare ecosystem, such as institutions, authorities, collective bodies of health scientists and pharmaceutical companies, as well as patient associations, providing our services to over 150 clients.